Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2013 2
2014 3
2015 3
2016 1
2018 4
2019 4
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
How to discuss gene therapy for haemophilia? A patient and physician perspective.
Miesbach W, O'Mahony B, Key NS, Makris M. Miesbach W, et al. Among authors: o mahony b. Haemophilia. 2019 Jul;25(4):545-557. doi: 10.1111/hae.13769. Epub 2019 May 21. Haemophilia. 2019. PMID: 31115117 Free PMC article. Review.
Gene therapy has the potential to revolutionise treatment for patients with haemophilia and is close to entering clinical practice. ...In making the shared decision to proceed with gene therapy for haemophilia, physicians should make it clear that research is ongoin …
Gene therapy has the potential to revolutionise treatment for patients with haemophilia and is close to entering clinical practice. . …
Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.
Booth J, Oladapo A, Walsh S, O'Hara J, Carroll L, Garcia Diego DA, O'Mahony B. Booth J, et al. Among authors: o mahony b. Haemophilia. 2018 Sep;24(5):e322-e327. doi: 10.1111/hae.13596. Epub 2018 Aug 9. Haemophilia. 2018. PMID: 30091822
INTRODUCTION: Clinical severity and impact of haemophilia on quality of life have been generally considered to be lower for haemophilia B (HB) compared with haemophilia A (HA) patients. ...Haemophilia type was not a significant predictor of ABR, target …
INTRODUCTION: Clinical severity and impact of haemophilia on quality of life have been generally considered to be lower for haemop
Achieving the unimaginable: Health equity in haemophilia.
Skinner MW, Nugent D, Wilton P, O'Mahony B, Dolan G, O'Hara J, Berntorp E. Skinner MW, et al. Among authors: o mahony b. Haemophilia. 2020 Jan;26(1):17-24. doi: 10.1111/hae.13862. Epub 2019 Nov 13. Haemophilia. 2020. PMID: 31724316 Review.
Historically, treatment based on the availability of clotting factor replacement has resulted in an arcane guideline for the correction of factor deficiencies in people with haemophilia (PwH). ...A treatment model was developed by a panel of haemophilia providers, p …
Historically, treatment based on the availability of clotting factor replacement has resulted in an arcane guideline for the correction of f …
Value of prophylaxis vs on-demand treatment: Application of a value framework in hemophilia.
Nugent D, O'Mahony B, Dolan G; International Haemophilia Access Strategy Council. Nugent D, et al. Among authors: o mahony b. Haemophilia. 2018 Sep;24(5):755-765. doi: 10.1111/hae.13589. Epub 2018 Aug 8. Haemophilia. 2018. PMID: 30088692
INTRODUCTION: Therapeutic advances over the past 30 years have led to longer life expectancy and improved quality of life (QOL) for persons with hemophilia. ...This analysis also demonstrates clinical utility of the value framework process in the determination of optimal a …
INTRODUCTION: Therapeutic advances over the past 30 years have led to longer life expectancy and improved quality of life (QOL) for persons …
Improving haemophilia patient care through sharing best practice.
de Moerloose P, Arnberg D, O'Mahony B, Colvin B. de Moerloose P, et al. Among authors: o mahony b. Eur J Haematol. 2015 Oct;95 Suppl 79:1-8. doi: 10.1111/ejh.12630. Eur J Haematol. 2015. PMID: 26338268
At the 2014 Annual Congress of the European Haemophilia Consortium (EHC) held in Belfast, Northern Ireland, Pfizer initiated and funded a satellite symposium entitled: 'Improving Patient Care Through Sharing Best Practice'. ...Finally, Brian O'Mahony reflected on the centr …
At the 2014 Annual Congress of the European Haemophilia Consortium (EHC) held in Belfast, Northern Ireland, Pfizer initiated and fund …
Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire.
Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther M, Iorio A. Chai-Adisaksopha C, et al. Among authors: o mahony b. BMJ Open. 2018 Aug 8;8(8):e021900. doi: 10.1136/bmjopen-2018-021900. BMJ Open. 2018. PMID: 30093520 Free PMC article.
Participants were enrolled if they were more than 10 years old and people with haemophilia A or B or people without a bleeding disorder. ...CONCLUSIONS: The results of this study suggest that PROBE is a valid questionnaire for evaluating PROs in people with haemophilia
Participants were enrolled if they were more than 10 years old and people with haemophilia A or B or people without a bleeding disord …
Managing Haemophilia for Life: 5th Haemophilia Global Summit.
Hermans C, Dolan G, Jennings I, Windyga J, Lobet S, Rodríguez-Merchán EC, Di Minno MN, Jiménez-Yuste V, O'Mahony B. Hermans C, et al. Among authors: o mahony b. Eur J Haematol. 2015 Oct;95 Suppl 78:1-25. doi: 10.1111/ejh.12617. Eur J Haematol. 2015. PMID: 26350039
The 5th Haemophilia Global Summit was held in Barcelona, Spain, in September 2014. The programme was designed by an independent Scientific Steering Committee of haemophilia experts and explored issues relevant to the practical management of haemophilia, as we …
The 5th Haemophilia Global Summit was held in Barcelona, Spain, in September 2014. The programme was designed by an independent Scien …
Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia.
Colvin B, Dolan G, Martinoli C, O'Mahony B. Colvin B, et al. Among authors: o mahony b. Eur J Haematol Suppl. 2013 May;(73):1-9. doi: 10.1111/ejh.12093. Eur J Haematol Suppl. 2013. PMID: 23570445
At the 25th Annual European Haemophilia Consortium (EHC) Congress held in Prague, Czech Republic, in October 2012, Pfizer sponsored a satellite symposium entitled: 'Understanding Health Outcomes: Focus on Haemophilia'. Co-chaired by Brian O'Mahony (President of the …
At the 25th Annual European Haemophilia Consortium (EHC) Congress held in Prague, Czech Republic, in October 2012, Pfizer sponsored a …
Exploring regional variations in the cross-cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study.
Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther MA, Iorio A. Chai-Adisaksopha C, et al. Among authors: o mahony b. Haemophilia. 2019 May;25(3):365-372. doi: 10.1111/hae.13703. Epub 2019 Mar 12. Haemophilia. 2019. PMID: 30861270
We used analysis of variance methods and multivariable regression to determine the relative contribution of the variance explained by region controlling for haemophilia diagnosis, age group and levels of educations. ...Age and haemophilia diagnosis contributed 3.42% …
We used analysis of variance methods and multivariable regression to determine the relative contribution of the variance explained by region …
The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands.
Berntorp E, Hart D, Mancuso ME, d'Oiron R, Perry D, O'Mahony B, Kaczmarek R, Crato M, Pasi J, Miners A, Carlsson KS, Kitchen S, Boehlen F, Giangrande P, Cebura E, Uitslager N, Osooli M, Janeckova D, Haldon R, Rivolta GF. Berntorp E, et al. Among authors: o mahony b. Eur J Haematol. 2016 Jul;97 Suppl 83:3-18. doi: 10.1111/ejh.12760. Eur J Haematol. 2016. PMID: 27272000
There are still many unmet challenges in haemophilia care. The first Team Haemophilia Education (THE) meeting, held on 7-8 May 2015 in Amsterdam, The Netherlands, aimed to promote the optimal care of haemophilia patients through education of the multidiscipli …
There are still many unmet challenges in haemophilia care. The first Team Haemophilia Education (THE) meeting, held on 7-8 May …
20 results
Jump to page
Feedback